Volker Diehl
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment 390
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research 136
- Oncology top 0.05%
- Viral-associated cancers and disorders 92
- CAR-T cell therapy research 37
- Neurology top 0.05%
- CNS Lymphoma Diagnosis and Treatment 60
- Immunology top 0.2%
- Immune Cell Function and Interaction 44
-
- Lung Cancer Treatments and Mutations 175
-
- Monoclonal and Polyclonal Antibodies Research 95
- Co-authors
- Andreas EngertGertrude HenleWerner HenleHans TeschAndreas JostingBeate PfistnerJeremy FranklinHartmut Kirchner
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Volker Diehl
679 papers receiving 29.9k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Pathology and Forensic Medicine 17.4k
- Genetics 6.2k
- Oncology 14.0k
- Neurology 5.5k
- Immunology 6.2k
Countries citing papers authored by Volker Diehl
This map shows the geographic impact of Volker Diehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Diehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Diehl more than expected).
Fields of papers citing papers by Volker Diehl
This network shows the impact of papers produced by Volker Diehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Diehl. The network helps show where Volker Diehl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Volker Diehl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 25 | |
| 2 | 2012 | 63 | |
| 3 | 2009 | 303 | |
| 4 | 2005 | 54 | |
| 5 | 2005 | 20 | |
| 6 | 2004 | 0 | |
| 7 | 2002 | 15 | |
| 8 | 2001 | 2 | |
| 9 | The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias. | 2001 | 37 |
| 10 | 2001 | 2 | |
| 11 | 2000 | 23 | |
| 12 | 1999 | 12 | |
| 13 | Die Therapie des Morbus Hodgkin | 1998 | 1 |
| 14 | 1997 | 19 | |
| 15 | 1994 | 1 | |
| 16 | 1994 | 10 | |
| 17 | 1992 | 3 | |
| 18 | 1991 | 4 | |
| 19 | Hodgkin's disease in adults preliminary results of the hd 1 hd 2 and hd 3 trials | 1986 | 1 |
| 20 | 1983 | 2 |
About Volker Diehl
Volker Diehl is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 696 papers that have together received 31.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (390 papers), Lung Cancer Treatments and Mutations (175 papers), Chronic Lymphocytic Leukemia Research (136 papers), Monoclonal and Polyclonal Antibodies Research (95 papers), Viral-associated cancers and disorders (92 papers), CNS Lymphoma Diagnosis and Treatment (60 papers), Immune Cell Function and Interaction (44 papers) and CAR-T cell therapy research (37 papers). The work is most often cited by research in Pathology and Forensic Medicine (17.4k citations), Genetics (6.2k citations) and Oncology (14.0k citations). Volker Diehl has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Andreas Engert, Gertrude Henle, Werner Henle, Hans Tesch, Andreas Josting, Beate Pfistner, Jeremy Franklin, Hartmut Kirchner, Dirk Hasenclever and M. Schaadt. Their work appears in journals such as Blood, Annals of Oncology, Journal of Clinical Oncology, Annals of Hematology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.